OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
18
Results
Show all
Save search
Copy query
Show results for
Unknown
(18)
Publication Date
Release Date
2025
(6)
2021
(5)
2022
(3)
2024
(2)
2026
(1)
2023
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Genetic and Epidemiological Insights Into Respiratory Syncytial Virus Infections: A Comparative Study of Hospitalized Versus Community Cases in Portugal (2021-2023).
Not available
S-EPMC12516350
|
biostudies-literature
Cite
Candida auris
in Intensive Care Setting: The First Case Reported in Portugal.
Not available
S-EPMC10455255
|
biostudies-literature
Cite
Genotypic and Phenotypic Characterization of Pathogenic
Escherichia coli
,
Salmonella
spp., and
Campylobacter
spp., in Free-Living Birds in Mainland Portugal.
Not available
S-EPMC9819048
|
biostudies-literature
Cite
SARS-CoV-2 introductions and early dynamics of the epidemic in Portugal.
Not available
S-EPMC9053228
|
biostudies-literature
Cite
Cross-sectional study on protective antibodies against influenza A virus subtypes and cross-protection against influenza A(H3N2) subclade K, Portugal, August 2025.
Not available
S-EPMC12905529
|
biostudies-literature
Cite
Effectiveness of long-acting monoclonal antibodies against laboratory-confirmed RSV in children aged < 24 months and hospitalised for severe acute respiratory infection, European pilot study, 2024 to 2025.
Not available
S-EPMC12633706
|
biostudies-literature
Cite
Hybrid, infection- and vaccination-induced protection against laboratory- confirmed SARS-CoV-2 infection in a European multi-centre prospective cohort of healthcare workers, 2021-2024.
Not available
S-EPMC12751633
|
biostudies-literature
Cite
Formyl-peptide receptor type 2 activation mitigates heart and lung damage in inflammatory arthritis
Not available
S-SCDT-10_1038-S44321-025-00227-1
|
biostudies-other
Cite
COVID-19 Vaccine Effectiveness in Autumn and Winter 2022 to 2023 Among Older Europeans.
Not available
S-EPMC11217869
|
biostudies-literature
Cite
Effectiveness of the XBB.1.5 COVID-19 Vaccines Against SARS-CoV-2 Hospitalisation Among Adults Aged ≥ 65 Years During the BA.2.86/JN.1 Predominant Period, VEBIS Hospital Study, Europe, November 2023 to May 2024.
Not available
S-EPMC11890973
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets